Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 7;25(1):1274.
doi: 10.1186/s12885-025-14506-0.

Detection and significance of HPV16 E5-specific productive transcripts in oropharyngeal carcinoma

Affiliations

Detection and significance of HPV16 E5-specific productive transcripts in oropharyngeal carcinoma

Maria Gabriella Donà et al. BMC Cancer. .

Abstract

Background: HPV16 is implicated in around 30% of oropharyngeal cancers (OPCs). HPV-associated OPCs generally show a better prognosis, but 20% deviate from this trend, indicating a need for better molecular profiling. HPV16-E5 is an oncoprotein encoded by an mRNA that undergoes extensive splicing, with only one specific transcript being translatable. The prognostic significance of this E5-productive transcript in HPV-related OPCs is not well-studied.

Methods: We retrospectively analysed 74 HPV16-positive OPC cases diagnosed between 2011 and 2021. FFPE tissue samples were used for p16, EGFR, and HLA-I analysis by immunohistochemistry while E5, productive E5, E6 and E7 transcripts were detected by qPCR. Survival analysis was conducted using Kaplan-Meier curves and log-rank tests.

Results: Productive HPV16-E5 transcripts were detected in 11.3% of OPCs. There was no significant association between HPV16-E5 transcripts and EGFR or HLA-I expression. However, the presence of the productive E5 transcript was associated with worse progression-free survival (PFS) (p = 0.0024). EGFR or HLA-I expression was not significantly associated with PFS (p = 0.17 and p = 0.93, respectively).

Conclusions: This study demonstrates for the first time the presence of E5-productive transcripts in HPV16-positive OPCs and its association with poorer PFS, highlighting its potential as a prognostic marker. Further research with larger cohorts is needed to validate these findings.

Keywords: E5 mRNA; EGFR; HLA-I; HPV; Oropharyngeal cancer (OPC); PFS; Transcripts.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: All enrolled patients signed an informed consent to the protocol approved by the IRCCS Regina Elena National Cancer Institute, Istituti Fisioterapici Ospitalieri, Institutional Review Board (RS 1443/20). The study was conducted in accordance with the Declaration of Helsinki. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Proportions of HPV16-associated OPC samples positive for the presence of HPV16 E5, E6, E7, and E5 productive mRNA.This figure highlights the differential expression of these viral transcripts in HPV16-positive OPCs, with the E5-specific productive mRNA being the least commonly detected
Fig. 2
Fig. 2
Immunostaining for EGFR and HLA-I in HPV16-associated OPCs. HPV16-associated tonsillar squamous cell carcinoma: Hematoxylin and Eosin staining (H&E); Negative EGFR staining; Intact HLA-I expression. HPV16-associated base of the tongue squamous cell carcinoma: H&E staining; Positive EGFR staining; HLA-I diffuse loss. 3′,3′ diaminobenzidine (DAB) was used as a chromogenic substrate. 200× magnification
Fig. 3
Fig. 3
Unadjusted Kaplan Meier curves illustrating progression-free survival (PFS) outcomes for the 71 HPV16-associated OPC patients with both a valid mRNA analysis and immunohistochemistry results. Patients are stratified according to the expression of HPV16-E5 mRNA, HPV16-E5 productive mRNA, EGFR, and HLA-I; p values for the log-rank test used to compare the survival curves are also reported

References

    1. Lu Y, Xie Z, Luo G, Yan H, Qian HZ, Fu L, Wang B, Huang R, Cao F, Lin H, You R, Tan L, Yu T, Chen M, Li C, Liu X, Lei W, Zou H. Global burden of oropharyngeal cancer attributable to human papillomavirus by anatomical subsite and geographic region. Cancer Epidemiol. 2022;78:102140. - PubMed
    1. Koskinen AI, Hemminki O, Försti A, Hemminki K. Incidence and survival in oral and pharyngeal cancers in Finland and Sweden through half century. BMC Cancer. 2022;2:22:227. - PMC - PubMed
    1. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;1:363:24–35. - PMC - PubMed
    1. Paolini F, Campo F, Iocca O, Manciocco V, De Virgilio A, De Pascale V, Moretto S, Dalfino G, Vidiri A, Blandino G, Pimpinelli F, Venuti A, Pellini R. It is time to improve the diagnostic workup of oropharyngeal cancer with Circulating tumor HPV DNA: systematic review and meta-analysis. Head Neck. 2023;45:2945–54. - PubMed
    1. Chang JL, Tsao YP, Liu DW, Huang SJ, Lee WH, Chen SL. The expression of HPV-16E5 protein in squamous neoplastic changes in the uterine cervix. J Biomed Sci. 2001;8:206–13. - PubMed

MeSH terms

LinkOut - more resources